---
title: "REGN Reports Encouraging Data on Gene Therapy for Genetic Hearing Loss  ( Revised ) "
description: "Regeneron's DB-OTO gene therapy shows hearing gains in nearly all CHORD study participants, with durable and meaningful improvements."
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/261401062.md"
published_at: "2025-10-16T09:01:49.000Z"
---

# REGN Reports Encouraging Data on Gene Therapy for Genetic Hearing Loss  ( Revised ) 

> Regeneron's DB-OTO gene therapy shows hearing gains in nearly all CHORD study participants, with durable and meaningful improvements.

Regeneron's DB-OTO gene therapy shows hearing gains in nearly all CHORD study participants, with durable and meaningful improvements.

### Related Stocks

- [REGN.US - Regeneron Pharma](https://longbridge.com/en/quote/REGN.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Regeneron Just Moved From Underperform To Buy - Here's Why | Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) has been upgraded from Underperform to Buy by Bank of America (BofA) Securi | [Link](https://longbridge.com/en/news/271840648.md) |
| EPS Creative Health Technology to acquire 16.23% of China Genetic | EPS Creative Health Technology to acquire 16.23% of China Genetic | [Link](https://longbridge.com/en/news/275820168.md) |
| Genflow Biosciences Reports Positive Interim Results for SIRT6 Gene Therapy in Aged Dogs | Genflow Biosciences plc has reported positive interim results from its SLAB clinical trial of SIRT6 gene therapy in aged | [Link](https://longbridge.com/en/news/275712514.md) |
| Genes Tech Says Resolution To Approve Scheme Approved By Scheme Shareholders | Genes Tech Group Holdings Co Ltd :RESOLUTION TO APPROVE SCHEME WAS APPROVED BY SCHEME SHAREHOLDERSREFERS TO PROPOSAL TO  | [Link](https://longbridge.com/en/news/275917336.md) |
| 08:57 ETJeffrey Modell Foundation to Host Renowned Immunologist for Virtual Talk on Gene Therapy for Primary Immunodeficiency | The Jeffrey Modell Foundation will host Dr. Donald B. Kohn for a virtual talk on gene therapy for Primary Immunodeficien | [Link](https://longbridge.com/en/news/275616825.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.